ABVC BioPharma, Inc. Debt Securities, Noncurrent
ABVC BioPharma, Inc. (ABVC) had Debt Securities, Noncurrent of $28.07 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments
us-gaap:DebtSecuritiesNoncurrent · last filed 2026-08-12
- 2026-06-30: Debt Securities, Noncurrent $28.07K.
- 2026-03-31: Debt Securities, Noncurrent $27.98K.
- 2025-12-31: Debt Securities, Noncurrent $28.74K.
- 2025-09-30: Debt Securities, Noncurrent $850.39K.
| Period end | Debt Securities, Noncurrent |
|---|---|
| 2026-06-30 | $28.07K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $27.98K 10-Q · filed 2026-05-18 |
| 2025-12-31 | $28.74K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $850.39K 10-Q/A · filed 2026-03-03 |
| 2025-06-30 | $884.39K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $779.79K 10-Q · filed 2025-04-30 |
| 2024-12-31 | $790.25K 10-Q/A · filed 2026-03-03 |
| 2024-09-30 | $816.16K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $798.02K 10-Q · filed 2024-08-14 |
| 2023-12-31 | $847.25K 10-K · filed 2025-04-15 |